Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane, Carboplatin, and Avastin in HER2-negative breast cancer
NCT00723125Phase 2Completed
- Start
- Sep 2008
- Primary completion
- May 2014
- Modality
- Polymer-based Nanoparticles, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel, bevacizumab, carboplatin in breast cancer. Started Sep 2008; status: completed.
02
Drugs
nab-paclitaxelbevacizumabcarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00723125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723125.